Pharmacy

The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week.

As vaccine-makers rush to prove efficacy in their tweaked COVID-19 boosters targeting omicron and regulators mark calendars for a rollout this fall, some experts say the process needs to be rushed, according to The New York Times. 

A federal judge in West Virginia has ruled in favor of three pharmaceutical companies accused of creating an opioid epidemic in parts of the state, The Hill reported July 4. 

San Francisco-based Alto Pharmacy has tapped Alicia Boler Davis, who was recently Amazon's senior vice president of global customer fulfillment, to be its CEO effective Sept. 1. 

By the end of the summer, New York City will bypass pharmacies and directly offer the antiviral drug Paxlovid at mobile test-to-treat sites, Bloomberg reported June 30. 

CVS Health has tapped Ahmed Hassan to be president of Omnicare, effective July 1, CVS confirmed to Becker's. Mr. Hassan previously was the vice president and general manager of pharmacy benefit manager care management.

A week after the Supreme Court struck down Roe v. Wade, the 1973 decision that guaranteed the constitutional right to abortion, pharmacy chains limited purchases to emergency contraceptives and companies selling abortion pills noted a surge in demand. 

Here are nine of the biggest actions pharmacy chains Walmart, Walgreens and CVS took so far this year, listed in order of Becker's Hospital Review's coverage:

The FDA told vaccine manufacturers June 30 to focus on leading omicron subvariants BA.4 and BA.5, two days after an independent panel voted to recommend modified omicron-targeted vaccines. 

Pfizer-BioNTech has inked a deal for $3.2 billion with the federal government to deliver 105 million COVID-19 adult and child vaccines by the end of summer 2022, according to a June 29 press release.